Compositions and methods for producing isoprene free of c5 hydrocarbons under decoupling conditions and/or safe operating ranges

US10774345B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10774345-B2
Application numberUS-201715677335-A
CountryUS
Kind codeB2
Filing dateAug 15, 2017
Priority dateJul 2, 2008
Publication dateSep 15, 2020
Grant dateSep 15, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention features methods for producing isoprene from cultured cells wherein the cells in the stationary phase. The invention also provides compositions that include these cultured cells and/or increased amount of isoprene. The invention also provides for systems that include a non-flammable concentration of isoprene in the gas phase. Additionally, the invention provides isoprene compositions, such as compositions with increased amount of isoprene or increased purity.

First claim

Opening claim text (preview).

What is claimed is: 1. A biologically produced composition comprising: (a) greater than 2 mg of isoprene; and (b) 2-methyl-3-buten-2-ol, and ethyl acetate, wherein the amount of at least one of the 2-methyl-3-buten-2-ol and ethyl acetate relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 2. The composition of claim 1 , wherein at least a portion of the isoprene is in the gas phase. 3. The composition of claim 1 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 90% (w/w), between about 0.01% to about 80% (w/w), between about 0.01% to about 50% (w/w), between about 0.01% to about 20% (w/w), between about 0.01% to about 10% (w/w), between about 0.02% to about 50% (w/w), between about 0.05% to about 50% (w/w), between about 0.1% to about 50% (w/w), or between about 0.1% to about 20% (w/w). 4. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 90% (w/w). 5. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 80% (w/w). 6. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 50% (w/w). 7. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 20% (w/w). 8. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.01% to about 10% (w/w). 9. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.02% to about 50% (w/w). 10. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.05% to about 50% (w/w). 11. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.1% to about 50% (w/w). 12. The composition of claim 3 , wherein the amount of the 2-methyl-3-buten-2-ol or ethyl acetate relative to the amount of the isoprene is between about 0.1% to about 20% (w/w). 13. The composition of claim 1 , further comprising (c) one or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the one or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 14. The composition of claim 1 , further comprising (c) two or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the two or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 15. The composition of claim 1 , further comprising (c) three or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the three or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 16. The composition of claim 1 , further comprising (c) four or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the four or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 17. The composition of claim 1 , further comprising (c) five or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the five or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 18. The composition of claim 1 , further comprising (c) six or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3,6-octatriene, and 2,3-cycloheptenolpyridine, wherein the amount of at least one of the six or more compounds relative to the amount of the isoprene is between about 0.01% to 105% (w/w). 19. The composition of claim 1 , further comprising (c) seven or more compounds selected from the group consisting of 2-heptanone, 6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine, 2,3,5-trimethylpyrazine, citronellal, acetaldehyde, methanethiol, methyl acetate, 1-propanol, diacetyl, 2-butanone, 2-methyl-1-propanol, 3-methyl-1-butanal, 3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol, ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl acetate, 3-methyl-3-buten-1-yl acetate, (E)-3,7-dimethyl-1,3,6-octatriene, (Z)-3,7-dimethyl-1,3

Assignees

Inventors

Classifications

  • C12N1/20Primary

    Bacteria; Culture media therefor · CPC title

  • acyclic {(C12P5/007 takes precedence)} · CPC title

  • Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title

  • for Bacillus · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10774345B2 cover?
The invention features methods for producing isoprene from cultured cells wherein the cells in the stationary phase. The invention also provides compositions that include these cultured cells and/or increased amount of isoprene. The invention also provides for systems that include a non-flammable concentration of isoprene in the gas phase. Additionally, the invention provides isoprene compositi…
Who is the assignee on this patent?
Danisco Us Inc, Goodyear Tire & Rubber
What technology area does this patent fall under?
Primary CPC classification C12N1/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).